726 related articles for article (PubMed ID: 15116014)
1. Early tumor necrosis factor-alpha release from the pulmonary macrophage in lung ischemia-reperfusion injury.
Naidu BV; Woolley SM; Farivar AS; Thomas R; Fraga CH; Goss CH; Mulligan MS
J Thorac Cardiovasc Surg; 2004 May; 127(5):1502-8. PubMed ID: 15116014
[TBL] [Abstract][Full Text] [Related]
2. The role of proinflammatory cytokines in lung ischemia-reperfusion injury.
Krishnadasan B; Naidu BV; Byrne K; Fraga C; Verrier ED; Mulligan MS
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):261-72. PubMed ID: 12579094
[TBL] [Abstract][Full Text] [Related]
3. Beta-chemokine function in experimental lung ischemia-reperfusion injury.
Krishnadasan B; Farivar AS; Naidu BV; Woolley SM; Byrne K; Fraga CH; Mulligan MS
Ann Thorac Surg; 2004 Mar; 77(3):1056-62. PubMed ID: 14992926
[TBL] [Abstract][Full Text] [Related]
4. Endotracheal calcineurin inhibition ameliorates injury in an experimental model of lung ischemia-reperfusion.
Woolley SM; Farivar AS; Naidu BV; Rosengart M; Thomas R; Fraga C; Mulligan MS
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):376-84. PubMed ID: 14762344
[TBL] [Abstract][Full Text] [Related]
5. Alpha chemokines regulate direct lung ischemia-reperfusion injury.
Farivar AS; Krishnadasan B; Naidu BV; Woolley SM; Verrier ED; Mulligan MS
J Heart Lung Transplant; 2004 May; 23(5):585-91. PubMed ID: 15135375
[TBL] [Abstract][Full Text] [Related]
6. Intratracheal poly (ADP) ribose synthetase inhibition ameliorates lung ischemia reperfusion injury.
Farivar AS; Woolley SM; Fraga CH; Thomas R; Salzman AL; Szabo C; Mulligan MS
Ann Thorac Surg; 2004 Jun; 77(6):1938-43. PubMed ID: 15172241
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary macrophage inhibition and inhaled nitric oxide attenuate lung ischemia-reperfusion injury.
Gazoni LM; Tribble CG; Zhao MQ; Unger EB; Farrar RA; Ellman PI; Fernandez LG; Laubach VE; Kron IL
Ann Thorac Surg; 2007 Jul; 84(1):247-53. PubMed ID: 17588423
[TBL] [Abstract][Full Text] [Related]
8. Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury.
Naidu BV; Krishnadasan B; Farivar AS; Woolley SM; Thomas R; Van Rooijen N; Verrier ED; Mulligan MS
J Thorac Cardiovasc Surg; 2003 Jul; 126(1):200-7. PubMed ID: 12878956
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between thrombosis and inflammation in lung reperfusion injury.
Farivar AS; Delgado MF; McCourtie AS; Barnes AD; Verrier ED; Mulligan MS
Ann Thorac Surg; 2006 Mar; 81(3):1061-7. PubMed ID: 16488723
[TBL] [Abstract][Full Text] [Related]
10. Depletion of alveolar macrophages by clodronate-liposomes aggravates ischemia-reperfusion injury of the lung.
Nakamura T; Abu-Dahab R; Menger MD; Schäfer U; Vollmar B; Wada H; Lehr CM; Schäfers HJ
J Heart Lung Transplant; 2005 Jan; 24(1):38-45. PubMed ID: 15653377
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats.
Wu H; Ren B; Zhu J; Dong G; Xu B; Wang C; Zheng X; Jing H
Eur J Cardiothorac Surg; 2006 Jun; 29(6):902-7. PubMed ID: 16675226
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats.
Ito K; Shimada J; Kato D; Toda S; Takagi T; Naito Y; Yoshikawa T; Kitamura N
Eur J Cardiothorac Surg; 2004 Apr; 25(4):530-6. PubMed ID: 15037267
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury.
Maxey TS; Enelow RI; Gaston B; Kron IL; Laubach VE; Doctor A
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):541-7. PubMed ID: 14762366
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary nitric oxide metabolism following infrarenal aortic cross-clamp-induced ischaemia-reperfusion injury.
Pararajasingam R; Weight SC; Bell PR; Nicholson ML; Sayers RD
Eur J Vasc Endovasc Surg; 2000 Jan; 19(1):47-51. PubMed ID: 10706834
[TBL] [Abstract][Full Text] [Related]
15. Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice.
Yoshidome H; Lentsch AB; Cheadle WG; Miller FN; Edwards MJ
J Surg Res; 1999 Jan; 81(1):33-7. PubMed ID: 9889054
[TBL] [Abstract][Full Text] [Related]
16. Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs.
Luh SP; Tsai CC; Shau WY; Chen JS; Kuo SH; Lin-Shiau SY; Lee YC
J Surg Res; 1999 Dec; 87(2):152-63. PubMed ID: 10600344
[TBL] [Abstract][Full Text] [Related]
17. Role of macrophage inflammatory protein-1 alpha (MIP-1 alpha) in acute lung injury in rats.
Shanley TP; Schmal H; Friedl HP; Jones ML; Ward PA
J Immunol; 1995 May; 154(9):4793-802. PubMed ID: 7722328
[TBL] [Abstract][Full Text] [Related]
18. Endothelin receptor antagonism by tezosentan attenuates lung injury induced by aortic ischemia-reperfusion.
Kiriş I; Narin C; Gülmen S; Yilmaz N; Sütçü R; Kapucuoğlu N
Ann Vasc Surg; 2009; 23(3):382-91. PubMed ID: 19135850
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin attenuates ischemia-reperfusion induced lung injury by inhibiting tumor necrosis factor-alpha and matrix metalloproteinase-9 expression.
Wu H; Dong G; Liu H; Xu B; Li D; Jing H
Eur J Pharmacol; 2009 Jan; 602(2-3):406-12. PubMed ID: 19061883
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil elastase inhibitor (sivelestat) attenuates subsequent ventilator-induced lung injury in mice.
Sakashita A; Nishimura Y; Nishiuma T; Takenaka K; Kobayashi K; Kotani Y; Yokoyama M
Eur J Pharmacol; 2007 Sep; 571(1):62-71. PubMed ID: 17599828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
